medigraphic.com
Instituto Nacional de Salud Pública

2002, Number 5

<< Back Next >>

salud publica mex 2002; 44 (5)

Mortality due to neural tube defects and risk factors in Hidalgo, Mexico.

Muñoz-Juárez S, Vargas-Flores H, Hernández-Prado B, López-Ríos O, Ortiz-Espinosa RM

Language: Spanish
References: 50
Page: 422-430
PDF size: 60.68 Kb.


ABSTRACT

Objective. To calculate the risk of fetal death due to neural tube defects and estimate associated factors in the state of Hidalgo, Mexico. Material and Methods. Data were abstracted from death certificates registered during 1990-1995 in the state of Hidalgo, Mexico. The design was a proportional mortality study, which is considered as a variant of the case control design. Cases were deaths with any type of neural tube defect, and controls were fetal deaths due to other causes. Results. A total of 3 673 fetal death certificates were analyzed; 8.06% had neural tube defects and the remaining died of other causes. Fetal death was associated with fetal weight less than 2500 grams (OR 5.0, 95% CI 3.6-6.8), being female (OR 1.7, 95% CI 1.3-2.3), and death during the late fetal period (OR 5.5, 95% CI 3.8-8.1). Conclusions. Results show that the risk of fetal death due to neural tube defects is greater among low birth weight babies, females, and during the late fetal period.


REFERENCES

  1. Secretaría de Salud. Norma Oficial Mexicana NOM-007-SSA2-1993, para la atención de la mujer durante el embarazo, parto, puerperio y del recién nacido. Criterios y procedimientos para la prestación de servicio. Diario Oficial de la Federación, 6 de enero de 1995.

  2. Langer A. Enfoques de la investigación perinatal. Salud Publica Mex 1988;30(1):43-46.

  3. Moore KL. Embriología clínica. 6 a edición. México, D.F.: McGraw Hill, 1999:304-341.

  4. Cedeño RR, León A, Romero R. Epidemiología de las malformaciones congénitas externas en una maternidad en Venezuela. Bol Med Hosp Infant Mex 1996;53:117-122.

  5. Mutchinick O, Lisker R, Babinski V. Programa mexicano de registro y vigilancia epidemiológica de malformaciones congénitas. Salud Publica Mex 1988;30:88-100.

  6. Hernández JL, Cortés GG, Aldana VC, Ramírez HA. Incidencia de malformaciones congénitas externas en el hospital de ginecopediatría no. 48 en León Guanajuato. Bol Med Hosp Infant Mex 1991;48:717-721.

  7. Cortés CR, Marín RR, Aguilar NS. Epidemiología de las malformaciones congénitas externas. Ginecol Obstet Mex 1986;54:311-321.

  8. Holmes LB. Congenital malformations. N Engl J Med 1980;295: 204-207.

  9. Castilla EE, Mutchinick O, Paz J, Muñoz E, Gelman Z. Estudio latinoamericano sobre malformaciones congénitas. Bol Oficina Sanit Panam 1974;76(6):494-501.

  10. Stevenson AC, Johnston HA, Stewart MIP. Congenital malformations: A report of series of consecutive births en 24 centers. Bull World Health Organ 1966;34(Suppl):9-127.

  11. Sánchez O, Salazar A, Ramírez N, Alvarez M. Epidemiología de malformaciones congénitas en el hospital Ruiz Páez de Ciudad Bolívar: una experiencia de 10 años. Invest clin 1989;30(3):159-172.

  12. Wald NJ, Cukle HS, Boreham J; Althouse R. Birth weight of infant with spina bifida cystica. Br J Obstet Gynaecol 1980;87(7):578-581.

  13. Baird D. Environment and reproduction. Br J Obstet Gynaecol 1980;87(12):1057-1067.

  14. Lian ZH, Yang HY, Li Z. Neural tube defects in Beijin-Tianjin area of China. Urban-rural distribution and some other epidemiological characteristics. J Epidemiol Community Health 1987;41(3):259-262.

  15. Xiao KZ. Epidemiology of neural tube defects in China. Chung Hua I Hsueh Tsa Chih 1989;69(4):189-191.

  16. Cobo A, García VA, Barriga A, López S, Nájera J. Frecuencia de malformaciones congénitas en recién nacidos vivos en León Guanajuato. Rev Invest Clin 1978;30:277-281.

  17. Hernández A, Corona R, Martínez B, Aguirre N, Cantú J. Factores prenatales y defectos congénitos en una población de 7 791 recién nacidos consecutivos. Bol Med Hosp Infant Mex 1983:40(7):363-366.

  18. Canún SS, Zafra RG. Detección de malformaciones congénitas externas. Bol Med Hosp Infant Mex 1984;41(1):21-24.

  19. Jiménez BE, Salamanca GF, Martínez AS, Bracho SM. Estudio de malformaciones congénitas en 105 825 nacimientos consecutivos. Bol Med Hosp Infant Mex 1985;42:744-748.

  20. Arredondo AG, Rodríguez BR, Treviño AG, Arreola AB, Astudillo CG, Russildi JM. Malformaciones congénitas en recién nacidos vivos. Bol Med Hosp Infant Mex 1990;47(12):882-827.

  21. Rothman KL. Modern epidemiology. Boston: Little Brown, 1986:51-76.

  22. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research. Principles and quantitative methods. Nueva York (NY): Van Nostrand Runhold, 1982:81-83.

  23. Miettinen OS, Wang J. An alternative to the proportionate mortality ratio. Am J Epidemiol 1981;114(1):144-148.

  24. Organización Mundial de la Salud. Clasificación Internacional de enfermedades. 9ª revisión. Ginebra: OMS, 1975:442-465.

  25. Sever LE. An epidemiologic study of neural tube defects in Los Angeles County II. Etiologic factors in an area with low prevalence at birth. Teratology 1982;25(3):323-334.

  26. Kulkarni ML, Mathew MA, Reddy V. The range of neural tube defects in Southern India. Arch Dis Child 1989;64(2):201-204.

  27. Crandall BF, Robinson L, Grau P. Risks associated with an elevated maternal serum alpha-fetoprotein level. Am J Obstet Gynecol 1991;165(3):581-586.

  28. Airede KI. Neural tube defects in the middle belt of Nigeria. J Trop Pediatr 1992;38(1):27-30.

  29. Smith NC. Detection of the fetus at risk. Eur J Clin Nutr 1992;46 (Suppl 1):S1-S5.

  30. Ogata AJ, Camano L, Brunoni D. Perinatal factors associated with neural tube defects (anencephaly [correction of anencephaly], spina bifida and encephalocele). Rev Paul Med 1992;110(4):147-151.

  31. Haddow JE, Palomaki GE, Holman MS. Young maternal age and smoking during pregnancy as risk factor for gastroschisis. Teratology 1993;47(3): 225-228.

  32. Kallen B, Cocchi G, Knudsen LB, Castilla EE, Robert E, Daltveit AK. International study of sex ratio and twinning of neural tube defects. Teratology 1994;50(5):322-331.

  33. Canfield MA, Annegers JF, Brender JD, Cooper SP, Greenberg F. Hispanic origin and neural tube defects in Houston/Harris County, Texas. II. Risk factors. Am J Epidemiol 1996;143(1):12-24.

  34. Dudin A. Neural tube defect among Palestinians: A hospital-based study. Ann Trop Paediatr 1997; 17(3):217-222.

  35. Wang Y, Zhu J, Wu Y. Dynamic variation of incidence of neural tube defects during 1988 to 1992 in China. Chung Hua I Hsueh Tsa Chih 1998;32(6):369-371.

  36. Wasserman CR, Shaw GM, Selvin S, Gould JB, Syme SL. Socioeconomic status, neighborhood social conditions, and neural tube defects. Am J Public Health 1998;88(11):1674-1680.

  37. Schlesselman JJ. Case control studies. Nueva York (NY): Oxford University Press, 1982: 227-280.

  38. 38.- Miettinen OS. Theorical epidemiology. Principles of occurrence research in medicine. Nueva York (NY): John Wiloy & Sons, 1985:260.

  39. Consejo Nacional de Población. Indice de marginación municipal. México, D.F.: Conapo, 1995:590-596.

  40. Olausson PO, Cnattingius S, Haglund B. Teenage pregnancies and risk of late fetal death and infant mortality. Br J Obstet Gynaecol 1999; 106(2):116-121.

  41. Rodríguez MM, Guerrero JF, Parra QM, Segura MJ, Levario CM, Sotelo EI. La deficiencia de ácido fólico y su asociación con defectos del tubo neural en el norte de México. Salud Publica Mex 1998;40(6):474-480.

  42. Croen LA, Shaw GM, Sanbonmatsu L, Selvin S, Buffler PA. Maternal residential proximity to hazardous waste sites and risk for selected congenital malformations. Epidemiology 1997;8(4):347-354.

  43. Organización Mundial de la Salud. Factores genéticos y malformaciones congénitas. Informe de un grupo de científicos de la OMS 1970. Ginebra: OMS, 1970; informe técnico no.438.

  44. Borman B, Cryer C. Fallacies of international and national comparisons of disease occurrence in the epidemiology of neural tube defects. Teratology 1990;42(4):405-412.

  45. Bernaschek G, Stuempflen Y, Deutinger J. The value of sonographic diagnosis of fetal malformations: Different results between indication based and screening based investigations. Prenat Diagn 1994;14(9):807-812.

  46. Hori E, Koyanagi T, Yoshizato T, Maeda H, Satoh S, Suita S. How antenatal ultrasound diagnosis of congenital malformations has contributed to fetal outcome: A 22 year review. Fetal Diagn Ther 1993;8(6):388-401.

  47. Smithells RW, Sheppard S. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980 Mar 22; I(8169):647.

  48. Tolarova M. Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip. Lancet 1982 Jul 24;2(8291):217.

  49. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-1835.

  50. Sean D, Mills JL, Malloy Am, Conley M, Lee YJ, Kirke PN et al. Minimum effective dose of folic acid for the food fortification to prevent the tube neural defects. Lancet 1997 Dec 6;350(9092):1666-1669.




2020     |     www.medigraphic.com